nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—SLC15A2—choroid plexus—brain cancer	0.0807	0.644	CbGeAlD
Cefuroxime—Nephropathy toxic—Lomustine—brain cancer	0.0277	0.0322	CcSEcCtD
Cefuroxime—Swollen tongue—Etoposide—brain cancer	0.0166	0.0193	CcSEcCtD
Cefuroxime—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.0133	0.0154	CcSEcCtD
Cefuroxime—Cefazolin—PON1—brain cancer	0.013	1	CrCbGaD
Cefuroxime—Digestion impaired—Hydroxyurea—brain cancer	0.0117	0.0136	CcSEcCtD
Cefuroxime—Nephropathy toxic—Carmustine—brain cancer	0.011	0.0128	CcSEcCtD
Cefuroxime—Pancytopenia—Lomustine—brain cancer	0.00948	0.011	CcSEcCtD
Cefuroxime—Digestion impaired—Temozolomide—brain cancer	0.00914	0.0106	CcSEcCtD
Cefuroxime—Renal failure—Lomustine—brain cancer	0.00875	0.0102	CcSEcCtD
Cefuroxime—Stomatitis—Lomustine—brain cancer	0.00868	0.0101	CcSEcCtD
Cefuroxime—Nephropathy toxic—Etoposide—brain cancer	0.00851	0.00988	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Procarbazine—brain cancer	0.00839	0.00974	CcSEcCtD
Cefuroxime—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00827	0.0096	CcSEcCtD
Cefuroxime—Creatinine increased—Hydroxyurea—brain cancer	0.00822	0.00954	CcSEcCtD
Cefuroxime—Haemolytic anaemia—Procarbazine—brain cancer	0.00813	0.00943	CcSEcCtD
Cefuroxime—Cholestasis—Temozolomide—brain cancer	0.00805	0.00934	CcSEcCtD
Cefuroxime—Haemoglobin—Lomustine—brain cancer	0.00803	0.00932	CcSEcCtD
Cefuroxime—Haemorrhage—Lomustine—brain cancer	0.00799	0.00928	CcSEcCtD
Cefuroxime—Injection site pain—Carmustine—brain cancer	0.00774	0.00899	CcSEcCtD
Cefuroxime—Blood urea increased—Hydroxyurea—brain cancer	0.00738	0.00857	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00661	0.00767	CcSEcCtD
Cefuroxime—Hepatic enzyme increased—Temozolomide—brain cancer	0.00646	0.0075	CcSEcCtD
Cefuroxime—Eosinophilia—Procarbazine—brain cancer	0.00628	0.00729	CcSEcCtD
Cefuroxime—Leukopenia—Lomustine—brain cancer	0.00623	0.00723	CcSEcCtD
Cefuroxime—Phosphatase alkaline increased—Temozolomide—brain cancer	0.00611	0.00709	CcSEcCtD
Cefuroxime—Vaginal inflammation—Temozolomide—brain cancer	0.00611	0.00709	CcSEcCtD
Cefuroxime—Candida infection—Carmustine—brain cancer	0.00604	0.00701	CcSEcCtD
Cefuroxime—Pancytopenia—Procarbazine—brain cancer	0.00602	0.00699	CcSEcCtD
Cefuroxime—Candida infection—Temozolomide—brain cancer	0.00583	0.00677	CcSEcCtD
Cefuroxime—Vaginal infection—Temozolomide—brain cancer	0.00577	0.00669	CcSEcCtD
Cefuroxime—Aplastic anaemia—Temozolomide—brain cancer	0.00574	0.00666	CcSEcCtD
Cefuroxime—SLC15A1—endocrine gland—brain cancer	0.00573	0.0457	CbGeAlD
Cefuroxime—SLC15A2—telencephalon—brain cancer	0.00568	0.0453	CbGeAlD
Cefuroxime—Drowsiness—Procarbazine—brain cancer	0.00565	0.00656	CcSEcCtD
Cefuroxime—Thrombocytopenia—Lomustine—brain cancer	0.00556	0.00645	CcSEcCtD
Cefuroxime—Pain—Carboplatin—brain cancer	0.00555	0.00644	CcSEcCtD
Cefuroxime—Jaundice—Procarbazine—brain cancer	0.00551	0.0064	CcSEcCtD
Cefuroxime—Stomatitis—Procarbazine—brain cancer	0.00551	0.0064	CcSEcCtD
Cefuroxime—Sweating—Procarbazine—brain cancer	0.00542	0.00629	CcSEcCtD
Cefuroxime—Anorexia—Lomustine—brain cancer	0.00541	0.00628	CcSEcCtD
Cefuroxime—Blood creatinine increased—Hydroxyurea—brain cancer	0.00532	0.00617	CcSEcCtD
Cefuroxime—Thrombophlebitis—Carmustine—brain cancer	0.0053	0.00615	CcSEcCtD
Cefuroxime—Body temperature increased—Carboplatin—brain cancer	0.00513	0.00596	CcSEcCtD
Cefuroxime—Thrombophlebitis—Temozolomide—brain cancer	0.00512	0.00595	CcSEcCtD
Cefuroxime—Haemoglobin—Procarbazine—brain cancer	0.0051	0.00592	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.0051	0.00592	CcSEcCtD
Cefuroxime—Haemorrhage—Procarbazine—brain cancer	0.00508	0.00589	CcSEcCtD
Cefuroxime—Decreased appetite—Lomustine—brain cancer	0.00494	0.00573	CcSEcCtD
Cefuroxime—Phosphatase alkaline increased—Etoposide—brain cancer	0.00489	0.00567	CcSEcCtD
Cefuroxime—Candida infection—Etoposide—brain cancer	0.00467	0.00542	CcSEcCtD
Cefuroxime—Thirst—Temozolomide—brain cancer	0.00466	0.00541	CcSEcCtD
Cefuroxime—Pancytopenia—Hydroxyurea—brain cancer	0.00466	0.00541	CcSEcCtD
Cefuroxime—SLC15A2—pituitary gland—brain cancer	0.00462	0.0369	CbGeAlD
Cefuroxime—Neutropenia—Hydroxyurea—brain cancer	0.00459	0.00533	CcSEcCtD
Cefuroxime—Dysuria—Hydroxyurea—brain cancer	0.00459	0.00533	CcSEcCtD
Cefuroxime—Chills—Procarbazine—brain cancer	0.00455	0.00528	CcSEcCtD
Cefuroxime—Body temperature increased—Lomustine—brain cancer	0.00449	0.00521	CcSEcCtD
Cefuroxime—SLC15A2—medulla oblongata—brain cancer	0.00446	0.0356	CbGeAlD
Cefuroxime—Mouth ulceration—Etoposide—brain cancer	0.00442	0.00513	CcSEcCtD
Cefuroxime—Infestation—Hydroxyurea—brain cancer	0.00438	0.00508	CcSEcCtD
Cefuroxime—Drowsiness—Hydroxyurea—brain cancer	0.00438	0.00508	CcSEcCtD
Cefuroxime—Infestation NOS—Hydroxyurea—brain cancer	0.00438	0.00508	CcSEcCtD
Cefuroxime—Stomatitis—Hydroxyurea—brain cancer	0.00426	0.00495	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00414	0.0048	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.00408	0.00474	CcSEcCtD
Cefuroxime—SLC15A2—midbrain—brain cancer	0.00408	0.0325	CbGeAlD
Cefuroxime—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00399	0.00464	CcSEcCtD
Cefuroxime—SLC15A2—spinal cord—brain cancer	0.00398	0.0317	CbGeAlD
Cefuroxime—Leukopenia—Procarbazine—brain cancer	0.00395	0.00459	CcSEcCtD
Cefuroxime—Haemoglobin—Hydroxyurea—brain cancer	0.00395	0.00458	CcSEcCtD
Cefuroxime—Haemorrhage—Hydroxyurea—brain cancer	0.00393	0.00456	CcSEcCtD
Cefuroxime—Cough—Procarbazine—brain cancer	0.00386	0.00447	CcSEcCtD
Cefuroxime—Convulsion—Procarbazine—brain cancer	0.00383	0.00444	CcSEcCtD
Cefuroxime—Pancytopenia—Carmustine—brain cancer	0.00377	0.00437	CcSEcCtD
Cefuroxime—Arthralgia—Procarbazine—brain cancer	0.00376	0.00437	CcSEcCtD
Cefuroxime—Neutropenia—Carmustine—brain cancer	0.00371	0.00431	CcSEcCtD
Cefuroxime—Bronchitis—Temozolomide—brain cancer	0.00369	0.00428	CcSEcCtD
Cefuroxime—Pancytopenia—Temozolomide—brain cancer	0.00364	0.00423	CcSEcCtD
Cefuroxime—Vomiting—Lomustine—brain cancer	0.00361	0.00419	CcSEcCtD
Cefuroxime—Dysuria—Temozolomide—brain cancer	0.00358	0.00416	CcSEcCtD
Cefuroxime—Neutropenia—Temozolomide—brain cancer	0.00358	0.00416	CcSEcCtD
Cefuroxime—SLC15A2—endocrine gland—brain cancer	0.00358	0.0286	CbGeAlD
Cefuroxime—Angiopathy—Hydroxyurea—brain cancer	0.00356	0.00414	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Temozolomide—brain cancer	0.00356	0.00413	CcSEcCtD
Cefuroxime—SLC15A2—head—brain cancer	0.00354	0.0282	CbGeAlD
Cefuroxime—Thrombocytopenia—Procarbazine—brain cancer	0.00353	0.0041	CcSEcCtD
Cefuroxime—Chills—Hydroxyurea—brain cancer	0.00352	0.00409	CcSEcCtD
Cefuroxime—Tachycardia—Procarbazine—brain cancer	0.00352	0.00408	CcSEcCtD
Cefuroxime—Hyperhidrosis—Procarbazine—brain cancer	0.00349	0.00405	CcSEcCtD
Cefuroxime—Renal failure—Carmustine—brain cancer	0.00348	0.00404	CcSEcCtD
Cefuroxime—Stomatitis—Carmustine—brain cancer	0.00345	0.004	CcSEcCtD
Cefuroxime—Urinary tract infection—Carmustine—brain cancer	0.00344	0.00399	CcSEcCtD
Cefuroxime—Anorexia—Procarbazine—brain cancer	0.00344	0.00399	CcSEcCtD
Cefuroxime—Erythema—Hydroxyurea—brain cancer	0.00342	0.00397	CcSEcCtD
Cefuroxime—Infestation NOS—Temozolomide—brain cancer	0.00342	0.00397	CcSEcCtD
Cefuroxime—Infestation—Temozolomide—brain cancer	0.00342	0.00397	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00339	0.00393	CcSEcCtD
Cefuroxime—Nausea—Lomustine—brain cancer	0.00337	0.00392	CcSEcCtD
Cefuroxime—Stomatitis—Temozolomide—brain cancer	0.00333	0.00387	CcSEcCtD
Cefuroxime—Urinary tract infection—Temozolomide—brain cancer	0.00332	0.00386	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00328	0.00381	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Temozolomide—brain cancer	0.00323	0.00375	CcSEcCtD
Cefuroxime—SLC15A2—central nervous system—brain cancer	0.00323	0.0257	CbGeAlD
Cefuroxime—Sinusitis—Temozolomide—brain cancer	0.00321	0.00372	CcSEcCtD
Cefuroxime—Somnolence—Procarbazine—brain cancer	0.00321	0.00372	CcSEcCtD
Cefuroxime—Cramp muscle—Etoposide—brain cancer	0.0032	0.00371	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Etoposide—brain cancer	0.0032	0.00371	CcSEcCtD
Cefuroxime—Haemoglobin—Carmustine—brain cancer	0.00319	0.0037	CcSEcCtD
Cefuroxime—Haemorrhage—Carmustine—brain cancer	0.00318	0.00369	CcSEcCtD
Cefuroxime—SLC15A2—cerebellum—brain cancer	0.00315	0.0252	CbGeAlD
Cefuroxime—Decreased appetite—Procarbazine—brain cancer	0.00313	0.00364	CcSEcCtD
Cefuroxime—Haemoglobin—Temozolomide—brain cancer	0.00308	0.00358	CcSEcCtD
Cefuroxime—Pain—Procarbazine—brain cancer	0.00308	0.00358	CcSEcCtD
Cefuroxime—Haemorrhage—Temozolomide—brain cancer	0.00307	0.00356	CcSEcCtD
Cefuroxime—Hepatitis—Temozolomide—brain cancer	0.00307	0.00356	CcSEcCtD
Cefuroxime—Leukopenia—Hydroxyurea—brain cancer	0.00306	0.00355	CcSEcCtD
Cefuroxime—Urinary tract disorder—Temozolomide—brain cancer	0.00303	0.00352	CcSEcCtD
Cefuroxime—Urethral disorder—Temozolomide—brain cancer	0.00301	0.00349	CcSEcCtD
Cefuroxime—Convulsion—Hydroxyurea—brain cancer	0.00296	0.00344	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Procarbazine—brain cancer	0.00295	0.00342	CcSEcCtD
Cefuroxime—Pancytopenia—Etoposide—brain cancer	0.00291	0.00338	CcSEcCtD
Cefuroxime—Erythema multiforme—Temozolomide—brain cancer	0.0029	0.00337	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00289	0.00336	CcSEcCtD
Cefuroxime—Neutropenia—Etoposide—brain cancer	0.00287	0.00333	CcSEcCtD
Cefuroxime—Urticaria—Procarbazine—brain cancer	0.00286	0.00332	CcSEcCtD
Cefuroxime—Abdominal pain—Procarbazine—brain cancer	0.00285	0.00331	CcSEcCtD
Cefuroxime—Body temperature increased—Procarbazine—brain cancer	0.00285	0.00331	CcSEcCtD
Cefuroxime—Angiopathy—Temozolomide—brain cancer	0.00278	0.00323	CcSEcCtD
Cefuroxime—Immune system disorder—Temozolomide—brain cancer	0.00277	0.00322	CcSEcCtD
Cefuroxime—Erythema—Carmustine—brain cancer	0.00276	0.00321	CcSEcCtD
Cefuroxime—Chills—Temozolomide—brain cancer	0.00275	0.0032	CcSEcCtD
Cefuroxime—Infestation NOS—Etoposide—brain cancer	0.00274	0.00317	CcSEcCtD
Cefuroxime—Infestation—Etoposide—brain cancer	0.00274	0.00317	CcSEcCtD
Cefuroxime—Thrombocytopenia—Hydroxyurea—brain cancer	0.00273	0.00317	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00271	0.00315	CcSEcCtD
Cefuroxime—Skin disorder—Hydroxyurea—brain cancer	0.00271	0.00315	CcSEcCtD
Cefuroxime—Renal failure—Etoposide—brain cancer	0.00269	0.00312	CcSEcCtD
Cefuroxime—Erythema—Temozolomide—brain cancer	0.00267	0.0031	CcSEcCtD
Cefuroxime—Stomatitis—Etoposide—brain cancer	0.00267	0.00309	CcSEcCtD
Cefuroxime—Jaundice—Etoposide—brain cancer	0.00267	0.00309	CcSEcCtD
Cefuroxime—Anorexia—Hydroxyurea—brain cancer	0.00266	0.00309	CcSEcCtD
Cefuroxime—Hypersensitivity—Procarbazine—brain cancer	0.00266	0.00308	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Etoposide—brain cancer	0.00259	0.003	CcSEcCtD
Cefuroxime—SLC15A2—brain—brain cancer	0.00256	0.0204	CbGeAlD
Cefuroxime—Agranulocytosis—Etoposide—brain cancer	0.00255	0.00296	CcSEcCtD
Cefuroxime—Pruritus—Procarbazine—brain cancer	0.00255	0.00296	CcSEcCtD
Cefuroxime—Agitation—Carmustine—brain cancer	0.00254	0.00295	CcSEcCtD
Cefuroxime—Dyspnoea—Hydroxyurea—brain cancer	0.00249	0.00289	CcSEcCtD
Cefuroxime—Somnolence—Hydroxyurea—brain cancer	0.00248	0.00288	CcSEcCtD
Cefuroxime—Leukopenia—Carmustine—brain cancer	0.00247	0.00287	CcSEcCtD
Cefuroxime—Diarrhoea—Procarbazine—brain cancer	0.00247	0.00286	CcSEcCtD
Cefuroxime—Dyspepsia—Hydroxyurea—brain cancer	0.00246	0.00285	CcSEcCtD
Cefuroxime—Agitation—Temozolomide—brain cancer	0.00245	0.00285	CcSEcCtD
Cefuroxime—Angioedema—Temozolomide—brain cancer	0.00244	0.00283	CcSEcCtD
Cefuroxime—Decreased appetite—Hydroxyurea—brain cancer	0.00243	0.00282	CcSEcCtD
Cefuroxime—Urinary tract disorder—Etoposide—brain cancer	0.00242	0.00281	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00241	0.0028	CcSEcCtD
Cefuroxime—Urethral disorder—Etoposide—brain cancer	0.00241	0.00279	CcSEcCtD
Cefuroxime—Convulsion—Carmustine—brain cancer	0.00239	0.00278	CcSEcCtD
Cefuroxime—Leukopenia—Temozolomide—brain cancer	0.00239	0.00277	CcSEcCtD
Cefuroxime—Pain—Hydroxyurea—brain cancer	0.00239	0.00277	CcSEcCtD
Cefuroxime—Dizziness—Procarbazine—brain cancer	0.00238	0.00277	CcSEcCtD
Cefuroxime—Palpitations—Temozolomide—brain cancer	0.00236	0.00274	CcSEcCtD
Cefuroxime—Chest pain—Carmustine—brain cancer	0.00235	0.00273	CcSEcCtD
Cefuroxime—Cough—Temozolomide—brain cancer	0.00233	0.00271	CcSEcCtD
Cefuroxime—Erythema multiforme—Etoposide—brain cancer	0.00232	0.00269	CcSEcCtD
Cefuroxime—Convulsion—Temozolomide—brain cancer	0.00231	0.00269	CcSEcCtD
Cefuroxime—Vomiting—Procarbazine—brain cancer	0.00229	0.00266	CcSEcCtD
Cefuroxime—Arthralgia—Temozolomide—brain cancer	0.00227	0.00264	CcSEcCtD
Cefuroxime—Rash—Procarbazine—brain cancer	0.00227	0.00264	CcSEcCtD
Cefuroxime—Dermatitis—Procarbazine—brain cancer	0.00227	0.00264	CcSEcCtD
Cefuroxime—Headache—Procarbazine—brain cancer	0.00226	0.00262	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00226	0.00262	CcSEcCtD
Cefuroxime—Angiopathy—Etoposide—brain cancer	0.00223	0.00259	CcSEcCtD
Cefuroxime—Immune system disorder—Etoposide—brain cancer	0.00222	0.00257	CcSEcCtD
Cefuroxime—Thrombocytopenia—Carmustine—brain cancer	0.00221	0.00256	CcSEcCtD
Cefuroxime—Body temperature increased—Hydroxyurea—brain cancer	0.00221	0.00256	CcSEcCtD
Cefuroxime—Chills—Etoposide—brain cancer	0.0022	0.00256	CcSEcCtD
Cefuroxime—Tachycardia—Carmustine—brain cancer	0.0022	0.00256	CcSEcCtD
Cefuroxime—Anaphylactic shock—Temozolomide—brain cancer	0.00218	0.00253	CcSEcCtD
Cefuroxime—Anorexia—Carmustine—brain cancer	0.00215	0.0025	CcSEcCtD
Cefuroxime—Nausea—Procarbazine—brain cancer	0.00214	0.00249	CcSEcCtD
Cefuroxime—Thrombocytopenia—Temozolomide—brain cancer	0.00213	0.00248	CcSEcCtD
Cefuroxime—Skin disorder—Temozolomide—brain cancer	0.00212	0.00246	CcSEcCtD
Cefuroxime—Hyperhidrosis—Temozolomide—brain cancer	0.00211	0.00245	CcSEcCtD
Cefuroxime—Anorexia—Temozolomide—brain cancer	0.00208	0.00241	CcSEcCtD
Cefuroxime—Hypersensitivity—Hydroxyurea—brain cancer	0.00206	0.00239	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Carmustine—brain cancer	0.00206	0.00239	CcSEcCtD
Cefuroxime—Muscle spasms—Etoposide—brain cancer	0.00205	0.00238	CcSEcCtD
Cefuroxime—Dyspnoea—Carmustine—brain cancer	0.00201	0.00233	CcSEcCtD
Cefuroxime—Somnolence—Carmustine—brain cancer	0.00201	0.00233	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00199	0.00231	CcSEcCtD
Cefuroxime—Decreased appetite—Carmustine—brain cancer	0.00196	0.00228	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Carmustine—brain cancer	0.00195	0.00226	CcSEcCtD
Cefuroxime—Dyspnoea—Temozolomide—brain cancer	0.00194	0.00226	CcSEcCtD
Cefuroxime—Somnolence—Temozolomide—brain cancer	0.00194	0.00225	CcSEcCtD
Cefuroxime—Pain—Carmustine—brain cancer	0.00193	0.00224	CcSEcCtD
Cefuroxime—Dyspepsia—Temozolomide—brain cancer	0.00192	0.00223	CcSEcCtD
Cefuroxime—Leukopenia—Etoposide—brain cancer	0.00191	0.00222	CcSEcCtD
Cefuroxime—Diarrhoea—Hydroxyurea—brain cancer	0.00191	0.00222	CcSEcCtD
Cefuroxime—Decreased appetite—Temozolomide—brain cancer	0.0019	0.0022	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Temozolomide—brain cancer	0.00188	0.00218	CcSEcCtD
Cefuroxime—Cough—Etoposide—brain cancer	0.00187	0.00216	CcSEcCtD
Cefuroxime—Pain—Temozolomide—brain cancer	0.00186	0.00216	CcSEcCtD
Cefuroxime—Convulsion—Etoposide—brain cancer	0.00185	0.00215	CcSEcCtD
Cefuroxime—Dizziness—Hydroxyurea—brain cancer	0.00185	0.00214	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Carmustine—brain cancer	0.00184	0.00214	CcSEcCtD
Cefuroxime—Chest pain—Etoposide—brain cancer	0.00182	0.00211	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00181	0.0021	CcSEcCtD
Cefuroxime—Abdominal pain—Carmustine—brain cancer	0.00178	0.00207	CcSEcCtD
Cefuroxime—Body temperature increased—Carmustine—brain cancer	0.00178	0.00207	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Temozolomide—brain cancer	0.00178	0.00207	CcSEcCtD
Cefuroxime—Vomiting—Hydroxyurea—brain cancer	0.00177	0.00206	CcSEcCtD
Cefuroxime—Rash—Hydroxyurea—brain cancer	0.00176	0.00204	CcSEcCtD
Cefuroxime—Dermatitis—Hydroxyurea—brain cancer	0.00176	0.00204	CcSEcCtD
Cefuroxime—Headache—Hydroxyurea—brain cancer	0.00175	0.00203	CcSEcCtD
Cefuroxime—Anaphylactic shock—Etoposide—brain cancer	0.00174	0.00202	CcSEcCtD
Cefuroxime—Urticaria—Temozolomide—brain cancer	0.00173	0.00201	CcSEcCtD
Cefuroxime—Abdominal pain—Temozolomide—brain cancer	0.00172	0.002	CcSEcCtD
Cefuroxime—Body temperature increased—Temozolomide—brain cancer	0.00172	0.002	CcSEcCtD
Cefuroxime—Thrombocytopenia—Etoposide—brain cancer	0.00171	0.00198	CcSEcCtD
Cefuroxime—Tachycardia—Etoposide—brain cancer	0.0017	0.00198	CcSEcCtD
Cefuroxime—Skin disorder—Etoposide—brain cancer	0.00169	0.00197	CcSEcCtD
Cefuroxime—Hyperhidrosis—Etoposide—brain cancer	0.00169	0.00196	CcSEcCtD
Cefuroxime—Anorexia—Etoposide—brain cancer	0.00166	0.00193	CcSEcCtD
Cefuroxime—Hypersensitivity—Carmustine—brain cancer	0.00166	0.00193	CcSEcCtD
Cefuroxime—Nausea—Hydroxyurea—brain cancer	0.00166	0.00192	CcSEcCtD
Cefuroxime—Hypersensitivity—Temozolomide—brain cancer	0.00161	0.00186	CcSEcCtD
Cefuroxime—Dyspnoea—Etoposide—brain cancer	0.00156	0.0018	CcSEcCtD
Cefuroxime—Somnolence—Etoposide—brain cancer	0.00155	0.0018	CcSEcCtD
Cefuroxime—Diarrhoea—Carmustine—brain cancer	0.00154	0.00179	CcSEcCtD
Cefuroxime—Pruritus—Temozolomide—brain cancer	0.00154	0.00179	CcSEcCtD
Cefuroxime—Decreased appetite—Etoposide—brain cancer	0.00152	0.00176	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Etoposide—brain cancer	0.00151	0.00175	CcSEcCtD
Cefuroxime—Dizziness—Carmustine—brain cancer	0.00149	0.00173	CcSEcCtD
Cefuroxime—Pain—Etoposide—brain cancer	0.00149	0.00173	CcSEcCtD
Cefuroxime—Diarrhoea—Temozolomide—brain cancer	0.00149	0.00173	CcSEcCtD
Cefuroxime—Dizziness—Temozolomide—brain cancer	0.00144	0.00167	CcSEcCtD
Cefuroxime—Vomiting—Carmustine—brain cancer	0.00143	0.00166	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Etoposide—brain cancer	0.00143	0.00166	CcSEcCtD
Cefuroxime—Rash—Carmustine—brain cancer	0.00142	0.00165	CcSEcCtD
Cefuroxime—Dermatitis—Carmustine—brain cancer	0.00142	0.00165	CcSEcCtD
Cefuroxime—Headache—Carmustine—brain cancer	0.00141	0.00164	CcSEcCtD
Cefuroxime—Vomiting—Temozolomide—brain cancer	0.00139	0.00161	CcSEcCtD
Cefuroxime—Urticaria—Etoposide—brain cancer	0.00139	0.00161	CcSEcCtD
Cefuroxime—Abdominal pain—Etoposide—brain cancer	0.00138	0.0016	CcSEcCtD
Cefuroxime—Body temperature increased—Etoposide—brain cancer	0.00138	0.0016	CcSEcCtD
Cefuroxime—Rash—Temozolomide—brain cancer	0.00137	0.0016	CcSEcCtD
Cefuroxime—Dermatitis—Temozolomide—brain cancer	0.00137	0.00159	CcSEcCtD
Cefuroxime—Headache—Temozolomide—brain cancer	0.00137	0.00158	CcSEcCtD
Cefuroxime—Nausea—Carmustine—brain cancer	0.00134	0.00156	CcSEcCtD
Cefuroxime—Nausea—Temozolomide—brain cancer	0.00129	0.0015	CcSEcCtD
Cefuroxime—Hypersensitivity—Etoposide—brain cancer	0.00129	0.00149	CcSEcCtD
Cefuroxime—Pruritus—Etoposide—brain cancer	0.00123	0.00143	CcSEcCtD
Cefuroxime—Diarrhoea—Etoposide—brain cancer	0.00119	0.00139	CcSEcCtD
Cefuroxime—Dizziness—Etoposide—brain cancer	0.00115	0.00134	CcSEcCtD
Cefuroxime—Vomiting—Etoposide—brain cancer	0.00111	0.00129	CcSEcCtD
Cefuroxime—Rash—Etoposide—brain cancer	0.0011	0.00128	CcSEcCtD
Cefuroxime—Dermatitis—Etoposide—brain cancer	0.0011	0.00128	CcSEcCtD
Cefuroxime—Headache—Etoposide—brain cancer	0.00109	0.00127	CcSEcCtD
Cefuroxime—Nausea—Etoposide—brain cancer	0.00104	0.0012	CcSEcCtD
